Therefore, overexpression of MMP-2 and MMP-9 may serve as indicators of metastatic phenotype, suggesting that monitoring changes in MMP expression following treatment could be a valuable marker for assessing treatment outcomes in patients with oral cancer [20]. The gene discussed is MMP2; the disease is lip and oral cavity carcinoma.